Esthesioneuroblastoma differential diagnosis: Difference between revisions
Simrat Sarai (talk | contribs) No edit summary |
Simrat Sarai (talk | contribs) No edit summary |
||
Line 16: | Line 16: | ||
*Pituitary macroadenoma | *Pituitary macroadenoma | ||
The following list describes the outcome of each of these diseases with various immunohistochemical tests. | |||
Distinguishing esthesioneuroblastomas from the other tumors is of paramount importance because the tumors respond differently to various treatment modalities. | |||
{| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | {| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align=center | ||
Line 71: | Line 74: | ||
|- | |- | ||
|} | |} | ||
==References== | ==References== |
Revision as of 15:07, 26 January 2016
Esthesioneuroblastoma Microchapters | |
Diagnosis | |
---|---|
Treatment | |
Case Studies | |
Esthesioneuroblastoma differential diagnosis On the Web | |
American Roentgen Ray Society Images of Esthesioneuroblastoma differential diagnosis | |
Risk calculators and risk factors for Esthesioneuroblastoma differential diagnosis | |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Simrat Sarai, M.D. [2]
Overview
Esthesioneuroblastoma must be differentiated from other tumors with similar histological appearance, such as lymphoma, Ewing sarcoma, melanoma, olfactory/ other [rhabdomyosarcoma or Merkel cell carcinoma], neuroblastoma, and small cell carcinoma.
Differential Diagnosis
The differential diagnosis of esthesioneuroblastoma includes the following:
- Olfactory neuroepithelioma
- Olfactory groove meningioma/haemangiopericytoma
- Sinonasal carcinoma (including SCC, minor salivary gland adenocarcinoma)
- Rhabdomyosarcoma
- Melanoma metastases
- Lymphoma
- Chordoma
- Juvenile nasopharyngeal angiofibroma
- Pituitary macroadenoma
The following list describes the outcome of each of these diseases with various immunohistochemical tests.
Distinguishing esthesioneuroblastomas from the other tumors is of paramount importance because the tumors respond differently to various treatment modalities.
Disease | Immunohistochemical Tests |
---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|